167 related articles for article (PubMed ID: 33402140)
1. Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study.
Bähler C; Brüngger B; Ulyte A; Schwenkglenks M; von Wyl V; Dressel H; Gruebner O; Wei W; Blozik E
BMC Public Health; 2021 Jan; 21(1):23. PubMed ID: 33402140
[TBL] [Abstract][Full Text] [Related]
2. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
Ulyte A; Wei W; Dressel H; Gruebner O; von Wyl V; Bähler C; Blozik E; Brüngger B; Schwenkglenks M
PLoS One; 2020; 15(4):e0231409. PubMed ID: 32298325
[TBL] [Abstract][Full Text] [Related]
3. Ten-year changes in colorectal cancer screening in Switzerland: The Swiss Health Interview Survey 2007, 2012 and 2017.
Schneider R; Syrogiannouli L; Bissig S; Scharf T; Bulliard JL; Ducros C; Del Giovane C; Tal K; Zwahlen M; Selby K; Auer R
Prev Med Rep; 2022 Jun; 27():101815. PubMed ID: 35656207
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of self-reported cancer-screening histories: a meta-analysis.
Rauscher GH; Johnson TP; Cho YI; Walk JA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):748-57. PubMed ID: 18381468
[TBL] [Abstract][Full Text] [Related]
5. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
6. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
[TBL] [Abstract][Full Text] [Related]
7. Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials.
Bretthauer M; Wieszczy P; Løberg M; Kaminski MF; Werner TF; Helsingen LM; Mori Y; Holme Ø; Adami HO; Kalager M
JAMA Intern Med; 2023 Nov; 183(11):1196-1203. PubMed ID: 37639247
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Stock C; Ihle P; Schubert I; Brenner H
Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
[TBL] [Abstract][Full Text] [Related]
10. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
Sirovich BE; Schwartz LM; Woloshin S
JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
[TBL] [Abstract][Full Text] [Related]
11. The role of health insurance coverage in cancer screening utilization.
Robinson JM; Shavers V
J Health Care Poor Underserved; 2008 Aug; 19(3):842-56. PubMed ID: 18677074
[TBL] [Abstract][Full Text] [Related]
12. Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012-2018: Evidence from Claims Data of a Large Insurance.
Schneider R; Näpflin M; Syrogiannouli L; Bissig S; Tal K; Bulliard JL; Ducros C; Senn O; Selby K; Bähler C; Blozik E; Auer R
Int J Public Health; 2021; 66():1604073. PubMed ID: 34744596
[No Abstract] [Full Text] [Related]
13. Factors Associated with Cancer Screening Among Hopi Men.
Batai K; Sanderson PR; Hsu CH; Joshweseoma L; Russell D; Joshweseoma L; Ojeda J; Burhansstipanov L; Brown SR; Ami D; Saboda K; Harris RB
J Cancer Educ; 2022 Aug; 37(4):915-923. PubMed ID: 33083892
[TBL] [Abstract][Full Text] [Related]
14. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
[TBL] [Abstract][Full Text] [Related]
15. Variation in colorectal cancer testing between primary care physicians: a cross-sectional study in Switzerland.
Braun AL; Prati E; Martin Y; Dvořák C; Tal K; Biller-Andorno N; Bulliard JL; Cornuz J; Selby K; Auer R
Int J Public Health; 2019 Sep; 64(7):1075-1083. PubMed ID: 31201428
[TBL] [Abstract][Full Text] [Related]
16. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
Spaeth A; Zwahlen M
Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
[TBL] [Abstract][Full Text] [Related]
17. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
[TBL] [Abstract][Full Text] [Related]
18. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.
Raffin E; Onega T; Bynum J; Austin A; Carmichael D; Bronner K; Goodney P; Hyams ES
Cancer Epidemiol; 2017 Oct; 50(Pt A):68-75. PubMed ID: 28822325
[TBL] [Abstract][Full Text] [Related]
19. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
20. Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort.
Harmon BE; Little MA; Woekel ED; Ettienne R; Long CR; Wilkens LR; Le Marchand L; Henderson BE; Kolonel LN; Maskarinec G
Cancer Epidemiol; 2014 Apr; 38(2):162-7. PubMed ID: 24667037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]